fda glp-1 crackdown news Beyond the Headlines: Warning Letters to Compounders The FDA's GLP-1 Compounding Crackdown

GLP-1 receptor agonists (GLP-1RAs) are well-established treatments for type 2 diabetes and obesity

One study found that after stopping tirzepatide, nearly 7 out of 10 users regained more than 5% of the weight theyd lost within a year, moving closer to their original weight

Regulation of mitochondrial bioenergetic function by hydrogen sulfide

When COVID hit, the DEA waived this requirement during the Public Health Emergency

First in the Philippines

[ Some reports reveal that physiological concentrations of uric acid could induce gene expression of macrophage-secreted inflammatory cytokines, such as monocyte chemoattractant protein-1 (MCP-1), and growth factors, such as platelet-derived growth factor